Shares of companies in billionaire Gautam Adani’s group have erased earlier losses that were triggered after a scathing short-seller report in 2023. Bloomberg and Business Standard both report that the rally continues as the market reevaluates the conglomerate’s prospects and as the company faces fewer near-term regulatory hurdles than before. The articles describe the move as part of a broader recovery in investor sentiment, allowing Adani’s listed firms to recoup declines associated with the Hindenburg allegations. While the outlets do not present new details of the original report or its specific findings, both accounts link the stock performance to improved conditions for the group, including easing regulatory pressures. The coverage also frames the development as an extension of a multi-month rebound, suggesting that the market’s willingness to buy Adani-related equities has strengthened sufficiently for the group to return to, or exceed, levels that previously reflected the post-report selloff. The reports present the recovery as ongoing rather than complete, and they emphasize changes in the regulatory environment and investor confidence rather than any single new corporate event.
Adani Group stocks regain losses tied to 2023 Hindenburg report
Shares of companies in billionaire Gautam Adani’s group have erased earlier losses that were triggered after a scathing short-seller report in 2023. Bloomberg and Business Standard both report that th...
- Adani Group companies’ shares have fully or largely erased losses linked to a 2023 Hindenburg short-seller report.
- Both outlets describe the recovery as extending through a continuing rally.
- The recovery is attributed to improving investor confidence.
- Both sources point to easing regulatory pressures as a factor.
- The articles describe the stock rebound as an ongoing development, not a one-time event.
Adani Group stocks have erased losses triggered by the 2023 Hindenburg report as investor confidence returns amid easing regulatory pressures
3 months agoShares of billionaire Gautam Adani’s group companies have erased all losses triggered by a scathing short-seller report in 2023, as the conglomerate overcomes regulatory challenges.
3 months ago
Samsung Biologics plans $2.2 billion rights offering to fund PolyPeptide acquisition
Samsung Biologics says it is raising about 3 trillion won (roughly $2.2 billion) through a rights offering to finance it...
Raghuram Rajan urges the US Fed to raise rates to contain persistent inflation
Former Reserve Bank of India governor Raghuram Rajan says the US Federal Reserve should raise interest rates to contain...
Oil prices rise as renewed U.S.-Iran strikes and shipping risks stoke supply fears
Oil prices move higher as renewed U.S.-Iran military actions and wider regional shipping concerns revive fears of crude...